US Biolab

Executive Summary

US Biolab is a private biospecimen procurement and logistics company based in Houston, Texas, founded in 1987. Leveraging a worldwide network of clinical sites and hospitals, the company provides custom biospecimen collection services tailored to research and project requirements in diagnostics and infectious disease. With over three decades of experience, US Biolab supports pharmaceutical, biotech, and academic clients by sourcing high-quality biological samples for assay development, clinical trials, and epidemiological studies. The company's ability to deliver unique sample solutions globally positions it as a critical partner in advancing precision medicine and infectious disease research. As demand for diverse, well-characterized biospecimens grows, US Biolab's established infrastructure and expertise offer a competitive advantage. The company operates without disclosed funding or valuation, suggesting a stable, privately held operation focused on service excellence rather than rapid growth. US Biolab's long-standing presence and specialized niche underscore its reliability in the diagnostics ecosystem.

Upcoming Catalysts (preview)

• Q3 2026New Strategic Partnership with a Major Pharma Company for Infectious Disease Trials70% success
• Q4 2026Expansion of Clinical Site Network into Emerging Markets (e.g., Southeast Asia)60% success
• Q1 2027Launch of a Specialized Biobank for Rare Infectious Disease Pathogens50% success